Bioplasmar
Bioplasmar29Bioplasmar
Bioplasmar is developing a novel plasma-based technology for advanced wound care and tissue regeneration.
About
What does Bioplasmar do?
Bioplasmar is a startup focused on developing and commercializing a proprietary plasma-based technology for medical applications. Their primary focus is on advanced wound care, aiming to accelerate healing and reduce infection rates. The technology also holds potential for tissue regeneration and other therapeutic uses.
Where is Bioplasmar headquartered?
Bioplasmar is headquartered in Tel Aviv, Israel.
When was Bioplasmar founded?
Bioplasmar was founded in 2011.
What industry does Bioplasmar operate in?
Bioplasmar operates in MedTech, HealthTech, Biotech, Wound Care, Plasma Technology, Medical Devices.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
Longevity and metabolic health platform offering personalized insights and interventions.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
“Edital Ref.ª CDL CTTRI 307 SGRH 2023 exercício de atividades de investigação na área científica de Química, com vista ao desenvolvimento de trabalhos de desenvolvimento de metodologias de deteção de microplásticos, assim como ensaios de bio…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.